AU Patent

AU2911601A — Novel immunoglobulin superfamily members apex-1, apex-2 and apex-3 and uses thereof

Assigned to Bristol Myers Squibb Co · Expires 2001-07-03 · 25y expired

What this patent protects

Patent listed against mipomersen-sodium.

Drugs covered by this patent

mipomersen-sodium (MIPOMERSEN SODIUM)

Patent Metadata

Patent number: AU2911601A
Jurisdiction: AU
Classification: —
Expires: 2001-07-03
Drug substance claim: No
Drug product claim: No
Assignee: Bristol Myers Squibb Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.